Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1995;91:802-812

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jugdutt, B. I.
Right arrow Articles by Blinston, G. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jugdutt, B. I.
Right arrow Articles by Blinston, G. E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ENALAPRIL MALEATE
Medline Plus Health Information
*Heart Attack

(Circulation. 1995;91:802-812.)
© 1995 American Heart Association, Inc.


Articles

Effect of Enalapril on Ventricular Remodeling and Function During Healing After Anterior Myocardial Infarction in the Dog

Bodh I. Jugdutt, MD, MSc, FRCPC; Mohammad I. Khan, MBBS; S. Joanne Jugdutt; Gordon E. Blinston, PhD

From the Cardiology Division of the Department of Medicine, University of Alberta, and University of Alberta Hospital, Edmonton, Canada.

Background Ventricular remodeling after myocardial infarction involves changes in ventricular size, shape, structure, and matrix that impact on function. Prolonged angiotensin-converting enzyme inhibition after infarction with captopril reduces ventricular enlargement and improves clinical outcome, but whether enalapril produces similar benefits is controversial.

Methods and Results The effect of enalapril during healing between 1 day and 6 weeks after myocardial infarction on in vivo changes in ventricular size, shape, mass, and function (asynergy, or akinesis and dyskinesis, and ejection fraction), as determined by serial two-dimensional echocardiography, hemodynamics, postmortem topography (planimetered short- and long-axis ventricular contours), and collagen content (determined by levels of hydroxyproline, a marker for collagen), was measured in 25 instrumented dogs. The dogs were randomized 1 day after left anterior descending coronary artery ligation to a control group (no treatment) and a group receiving oral enalapril (2.5 mg BID). Compared with no treatment, enalapril produced a sustained lowering of left atrial pressure but no difference in heart rate and mean blood pressure over the 6 weeks. Also compared with no treatment, enalapril modified in vivo remodeling parameters between 1 day and 6 weeks, with less elongation of the asynergy-containing segment, a lower expansion index (ratio of endocardial lengths of infarct to non–infarct-containing segments demarcated by papillary muscle landmarks), less scar wall thinning, a lower thinning ratio (ratio of average thickness of infarcted wall to average thickness of the normal wall), smaller ventricular volume, less regional bulging and aneurysm frequency, prevention of the increase in ventricular mass, less total extent of asynergy, and higher volume ejection fraction. At postmortem examination, scar mass was similar in the two groups, but topographic maps with enalapril revealed less infarct bulging, flatter infarct scars, and less noninfarct wall thickness. In addition, postmortem collagen content was similar in noninfarct zones of the two groups but lower in infarct zones of the dogs given enalapril.

Conclusions Prolonged enalapril therapy, in a dose that did not lower blood pressure, during healing after anterior infarction produced prolonged reduction of left ventricular preload in dogs. This diastolic unloading was associated with limitation of remodeling parameters (infarct expansion and thinning, progressive ventricular dilation and hypertrophy, and regional bulging), less total asynergy, and improved left ventricular ejection fraction. Although angiotensin-converting enzyme inhibition was associated with lower collagen content in the infarct area and altered scar topography, these effects did not impact negatively on overall remodeling and function.


Key Words: myocardial infarction • ventricles




This article has been cited by other articles:


Home page
CirculationHome page
S. Ichihara, T. Senbonmatsu, E. Price Jr, T. Ichiki, F. A. Gaffney, and T. Inagami
Targeted Deletion of Angiotensin II Type 2 Receptor Caused Cardiac Rupture After Acute Myocardial Infarction
Circulation, October 22, 2002; 106(17): 2244 - 2249.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
B. I. Jugdutt and V. Menon
Beneficial Effects of Therapy on the Progression of Structural Remodeling During Healing After Reperfused and Nonreperfused Myocardial Infarction: Different Effects on Different Parameters
Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2002; 7(2): 95 - 107.
[Abstract] [PDF]


Home page
CirculationHome page
J. I. Nwogu, D. Geenen, M. Bean, M. C. Brenner, X. Huang, and P. M. Buttrick
Inhibition of Collagen Synthesis With Prolyl 4-Hydroxylase Inhibitor Improves Left Ventricular Function and Alters the Pattern of Left Ventricular Dilatation After Myocardial Infarction
Circulation, October 30, 2001; 104(18): 2216 - 2221.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Sun and K. T. Weber
Infarct scar: a dynamic tissue
Cardiovasc Res, May 1, 2000; 46(2): 250 - 256.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
D. W. O'Brien, Y. Xu, V. Menon, and B. I. Jugdutt
Efficacy of Pretreatment With the Angiotensin II Type 1 Receptor Blocker UP269-6 and Losartan in the Dog: Effect on Hemodynamics and Ischemia-Reperfusion
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(2): 129 - 137.
[Abstract] [PDF]


Home page
HypertensionHome page
A. M. Gallagher, H. Yu, and M. P. Printz
Bradykinin-Induced Reductions in Collagen Gene Expression Involve Prostacyclin
Hypertension, July 1, 1998; 32(1): 84 - 88.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. T. Weber
Extracellular Matrix Remodeling in Heart Failure : A Role for De Novo Angiotensin II Generation
Circulation, December 2, 1997; 96(11): 4065 - 4082.
[Full Text]


Home page
CirculationHome page
P. Uusimaa, J. Risteli, M. Niemela, J. Lumme, M. Ikaheimo, A. Jounela, and K. Peuhkurinen
Collagen Scar Formation After Acute Myocardial Infarction : Relationships to Infarct Size, Left Ventricular Function, and Coronary Artery Patency
Circulation, October 21, 1997; 96(8): 2565 - 2572.
[Abstract] [Full Text]


Home page
CirculationHome page
K. C. Wollert, R. Studer, K. Doerfer, E. Schieffer, C. Holubarsch, H. Just, and H. Drexler
Differential Effects of Kinins on Cardiomyocyte Hypertrophy and Interstitial Collagen Matrix in the Surviving Myocardium After Myocardial Infarction in the Rat
Circulation, April 1, 1997; 95(7): 1910 - 1917.
[Abstract] [Full Text]


Home page
CirculationHome page
B. I. Jugdutt, M. J. Joljart, and M. I. Khan
Rate of Collagen Deposition During Healing and Ventricular Remodeling After Myocardial Infarction in Rat and Dog Models
Circulation, July 1, 1996; 94(1): 94 - 101.
[Abstract] [Full Text]